The National and Kapodistrian University of Athens (UoA)

The National and Kapodistrian University of Athens (UoA) is the largest state institution of higher learning in Greece, and among the largest universities in Europe. As all other Greek universities, it is a self-governed legal entity of public law. All its funds are invested into the management and operation of educational, research and cultural programmes, into student and staff services and grants. With a student body of about 68.500 undergraduate and postgraduate students, over 2.100 members of academic staff and
approximately 1.000 administrative and secretarial staff and specialised personnel, the UoA aims at excellence in both teaching and research in a significantly varied range of disciplines. UoA ranks in the 16th position in Europe and in the 89th position worldwide according to the Top Universities by Top Google Scholar Citations ranking system. UoA is one of the 11 leading research higher education institutions across Europe which have formed CIVIS, Europe’s Civic University Alliance. CIVIS brings together a community of more than 470,000 students and 58,000 staff members including 35,000 academics and
researchers, while recently it has partnered with 6 prestigious African Universities. UoA currently chairs one of the 5 CIVIS hubs.
The School of Medicine is operating since 1837 and has active presence nationally and internationally. Today the educational work of the 628 Professors concerns over 2.500 undergraduates, 3.000 graduate students and 3.000 doctoral candidates. Recent research work constitutes the UoA School of Medicine as one of the world’s leading Medical Institutions (according to the 2023 Shanghai Ranking’s Global Ranking of Academic Subjects, the UoA School of Medicine ranks in the top 100 in the field of Clinical Medicine).
Apart from pursuing research in all relevant areas, the UoA School of Medicine offers clinical and educational services of the highest standards.

Role of institution in the project

UoA acts as a data provider. The datasets expected to be provided within the 2-year implementation period are: a) A dataset of ~ 80 sarcomas (pre-radiotherapy CTs and/or MRIs with tumor segmentation, core biopsy results, post-radiotherapy MRIs and histopathological info following surgical excision). b) A dataset of approximately 240 primary brain tumors (e.g., 120 IDH-mutant and IDH wild type gliomas). The MRI-based dataset will also include various morphological and functional imaging subsets. c) A dataset of ~ 50 pre-biopsy MRI exams, accompanied by clinical/biochemical/histopathological (if available) Information. UoA has set up a federated node, which can be used for data sharing.

Ioannis Seimeni

Ioannis Seimenis is a medical physicist, board-certified in both ionising and non-ionising radiation physics. Ioannis is currently serving as Professor of Medical Physics at the University of Athens, whilst in the past, he held a series of posts in the medical industry and in the private healthcare sector. Ioannis is currently the elected president of the Hellenic Federation of University Teachers’ Associations and the elected vice-president of the Hellenic Association of Medical Physicists. He chairs the Committee of the Greek Atomic Energy Commission for the certification of Radioprotection Experts in medical exposures and he is a member of the Ministry of Health Committee for Ionising and non-Ιonising Radiations. He currently serves as the EFOMP (European Federation of Organisations for Medical Physics) representative in the Programme Planning Committee of the European Congress of Radiology, while he is one of the founding members of the EFOMP Special Interest Group in MRI. Ioannis has co-authored 151 peer-reviewed scientific publications, as well as 169 peer-reviewed abstracts in international conference proceedings and has given numerous invited talks in national and international Scientific Meetings. Ioannis has participated, as senior investigator or scientific coordinator, in 33 competitive research projects funded by national and international research promoting bodies.

Georgios Velonakis

Georgios Velonakis is a Radiologist subspecialized on Neuroradiology. He serves as an Assistant Professor of Radiology at the National and Kapodistrian University of Athens, Greece and he is the Director of the elective course “Neuroradiology”. He is holder of the European Diploma in Neuroradiology (EDiNR) and the European Diploma in Pediatric Neuroradiology (EDiPNR). He obtained his “Diploma in Medicine” and his Master of Science in “Interventional Radiology” from the Medical School of the National and Kapodistrian University of Athens, and he completed his PHD on “Percutaneous stabilization of vertebral fractures A2 according to the Magerl classification”. He completed his Radiology specialty training, at the 2nd Department of Radiology of the University of Athens, Attikon General University Hospital. He has attended a Neuroradiology Fellowship, University Hospitals Leuven, University of Leuven (KU Leuven), Belgium, which was sponsored by the European Society of Radiology (ESR) the European Society of Neuroradiology (ESNR), and the European School of Radiology. He has been working as a Senior Consultant Radiologist focusing on Neuroradiology and MRI since 2013. He is an author/coauthor in more than 137 publications on the Pubmed Database (h-index 22). He has participated in more than 8 research projects funded by national or international sources.

Dr. Eleftherios Pappas

Dr. Eleftherios Pappas is an Assistant Professor of Medical Physics – Radiation Physics at the Medical Physics Laboratory, Medical School, University of Athens. With a Ph.D. and postdoctoral research in Medical Physics, he has extensive academic and clinical experience in radiotherapy, dosimetry and medical image processing. Previously, he served as a clinical Medical Physicist at a private clinic and contributed to research and development of companies in the commercial sector. His research interests include -inter alia-Experimental dosimetry in Radiotherapy and Stereotactic Radiosurgery applications, Quality Assurance in advanced Radiotherapy treatment modalities, Computational (Monte Carlo) dosimetry in Radiotherapy and Stereotactic Radiosurgery, 3D dosimetry in Radiotherapy using Optical Computed Tomography, Evaluation and correction of MR images employed in Stereotactic Radiosurgery applications. Since 2013, he has co-authored over 30 peer-reviewed articles, and a book chapter. He actively contributes as an Associate Editor for the Journal of Applied Clinical Medical Physics and reviews for leading medical physics journals. His teaching responsibilities span undergraduate and postgraduate programs, focusing on dosimetry, radiotherapy and radiation protection. He supervises multiple MSc and Ph.D. theses. A member of esteemed professional organizations such as EFOMP and ESTRO, Dr. Pappas continues to advance medical physics through research, education, and clinical practice.

Mr. Evangelos Pantelis

Mr. Evangelos Pantelis holds a BSc degree in Physics, an MSc in Medical Physics, and a PhD in Physics from the National and Kapodistrian University of Athens (NKUoA). He currently serves as Associate Professor in the Medical Physics laboratory at the Medical School of the NKUoA. He has more than 18 years of experience in stereotactic radiosurgery and radiotherapy. His research interests focus on the clinical applications of ionizing radiation. In particular they concern the optimization of modern radiotherapy applications, including image-guided radiotherapy and stereotactic radiotherapy / radiosurgery and intensity modulated radiotherapy. Mr. Pantelis has co-authored 71 original papers published in international peer-reviewed scientific journals, which have received over 1,440 citations (source: Scopus, March 2025). His research has also been presented at 70 local and international scientific conferences. Additionally, he co-edited the book CyberKnife NeuroRadiosurgery: A Practical Guide (ISBN: 9783030506681) and contributed six chapters to multi-authored scientific books.

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Find out more

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

WATCH THE RECORDING

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

Sign up for more information

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.

Participate